Analysts rate Bionano Genomics Inc with a consensus Strong Buy and a 12-month average target price of $9.50 per share.
Based on the Bionano Genomics Inc stock forecasts from 2 analysts, the average analyst target price for Bionano Genomics Inc is USD 9.50 over the next 12 months. Bionano Genomics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bionano Genomics Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Bionano Genomics Inc’s stock price was USD 1.82. Bionano Genomics Inc’s stock price has changed by +18.18% over the past week, +12.35% over the past month and -69.51% over the last year.
What we like:
There is nothing we particularly like
What we don’t like:
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.